1) Tacrolimus(TM)
他克莫司(TM)
2) tacrolimus
他克莫司
1.
Progress in fermentation of tacrolimus;
发酵法生产他克莫司的研究进展
2.
Influence of CYP 3A5*3 genetic polymorphism on tacrolimus pharmacokinetics in renal transplant recipients;
CYP 3A5*3基因多态性对肾移植术后他克莫司药代动力学的影响
3.
Analysis of Blood Tacrolimus Concentrations in Renal Transplant Recipients;
肾移植患者全血他克莫司浓度监测结果分析
3) FK506
他克莫司
1.
Quality Evaluation and Design of Quality Control Rule for FK506 TDM by MEIA;
微粒子酶免分析法测定他克莫司血药浓度的质量评价及质控规则设计
2.
Favorable effect of chitosan sustained-release FK506 incorporated conduits on axonal regeneration in rat sciatic nerve;
壳聚糖复合他克莫司缓释鞘管促进大鼠坐骨神经再生的实验研究
3.
An in vitro model of hair follicle damage induced by Ara-c and reversal effect of FK506;
阿糖胞苷引起毛囊损伤离体模型的建立以及他克莫司对其的逆转作用
4) tacrolimus(FK506)
他克莫司
1.
OBJECTIVE To investigate the damage of tacrolimus(FK506) to small intestinal mucosa barrier and the protective effect of glutamine(Gln)for the damage.
目的观察他克莫司(FK506)对肠黏膜屏障的损伤以及谷氨酰胺(Gln)对该损伤的保护作用,并探讨其作用机制。
2.
OBJECTIVE:To objectively evaluate the immunosuppressive effect and safety of tacrolimus(FK506)in renal transplant recipients.
目的 :评价他克莫司 (FK506)用于肾移植患者免疫抑制治疗的效果与安全性。
3.
LC-MS/MS method monitoring tacrolimus(FK506) in human whole blood for therapeutic drug monitoring(TDM) was developed.
建立高效液相色谱-质谱联用法监测人全血中他克莫司浓度。
5) tacrolimus(FK506)
他克莫司(FK506)
6) tacrolimus capsules
他克莫司胶囊
1.
Determination of tacrolimus capsules by HPLC;
HPLC法测定他克莫司胶囊的含量
2.
Objective To establish RP-HPLC method for the content determinati on of tacrolimus capsules.
目的探讨用反相高效液相色谱法测定他克莫司胶囊中他克莫司含量。
补充资料：他克莫司
分子式：C44H69NO12
分子量：804.02
CAS号：104987-11-3
性质：
分子量：804.02
CAS号：104987-11-3
性质：
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条